In a study of men on active surveillance for low-risk prostate cancer, multiparametric magnetic resonance imaging by itself missed about one-fifth of men who had pathologic upgrading on subsequent biopsies.
Compared with ureteroscopy for kidney and ureteral stones, shock wave lithotripsy is significantly associated with 20% increased odds of re-treatment, a study found.
Disparities in access to medical care are among the factors thought to contribute to geographic variations in prostate cancer death rates and the treatments patients receive.
In an address during the American Urological Association’s 2020 Live Virtual Experience, Anthony S. Fauci, MD, a member of the White House Coronavirus Task Force, said the coronavirus pandemic is nowhere near over, but public health measures are making a big difference in reducing the number of cases and related deaths.
A new analysis looking at the effect of PSA screening on prostate cancer mortality over a 25-year period found a more favorable balance of benefits and harms than the 16-year estimates from the European Randomized Study of Screening for Prostate Cancer.
Three major medical organizations have issued recommendations for the diagnosis and treatment of advanced prostate cancer, including metastatic hormone-sensitive disease and nonmetastatic and metastatic castration-resistant disease.
Rates of peritonitis among patients on peritoneal dialysis, in episodes per patient-year, varied from 0.40 in Thailand to 0.26 in the United States, a study found.
Injection of a hydrogel spacer to provide prostate-rectum separation during radiation therapy for prostate cancer is associated with decreased radiation-induced rectal toxic effects, according to a new systematic review and meta-analysis.